Single Use Bioreactors Market Regional Analysis

North America maintained a huge dominance and is expected to continue a leading position owing to the presence of significant operating players and the region's well-established biopharmaceutical industry. Additionally, the region's increased manufacturing capacity has added to the market expansion. For instance, Thermo Fisher Scientific announced in September 2021 that it intended to build a new manufacturing facility specifically for single-use bioprocessing products. The addition of the Nashville location increased its network of SUT manufacturing facilities on a global scale. The changing environment for manufacturing and bioprocessing is a key driver of market expansion in the United States.

Asia Pacific is projected to register the fastest CAGR throughout the forecast period. It is estimated that about 50% of the new bioprocessing facilities across the globe are being established by Asian companies, including domestic players and international giants. In the near future, this is anticipated to significantly drive the Asia Pacific market. Due to its widespread use of single-use technology, China is predicted to be at the forefront.